Varicella zoster virus antibody titers after intravenous zoster immune globulin in neonates, and the safety of this preparation

2005 ◽  
Vol 94 (6) ◽  
pp. 790-793 ◽  
Author(s):  
Teresa Murguía-de-Sierra ◽  
Mónica Villa-Guillén ◽  
Dina Villanueva-García ◽  
Antide Molina ◽  
Alejandra Juárez-Chávez ◽  
...  
2007 ◽  
Vol 94 (6) ◽  
pp. 790-793 ◽  
Author(s):  
Teresa Murguía-de-Sierra ◽  
Mónica Villa-Guillén ◽  
Dina Villanueva-García ◽  
Antide Molina ◽  
Alejandra Juárez-Chávez ◽  
...  

2016 ◽  
Vol 3 (suppl_1) ◽  
Author(s):  
Heather Pomerantz ◽  
Xiaohe Xu ◽  
James White ◽  
T.S. Sunil ◽  
Robert Deiss ◽  
...  

Author(s):  
Andrew Woodhouse

Chickenpox is caused by varicella-zoster virus and is predominantly a self-limiting disease of childhood. Chickenpox in adults is more likely to be associated with complications such as varicella pneumonia. Treatment with antivirals is helpful in adults if given early after the onset of rash in uncomplicated disease. In complicated disease such as pneumonia, intravenous treatment is essential to optimize drug levels although an evidence base for this is lacking. Exposure to varicella during pregnancy is a particular concern for non-immune women and passive immunization with varicella immune globulin is indicated.


2007 ◽  
Vol 122 (2) ◽  
pp. 170-176 ◽  
Author(s):  
S-I Chitose ◽  
H Umeno ◽  
S Hamakawa ◽  
T Nakashima ◽  
H Shoji

AbstractThe relationship between varicella-zoster virus and idiopathic associated laryngeal paralysis was examined in five patients, using complement fixation or enzyme immunoassay testing. In all cases, significant changes in serum levels of varicella-zoster virus antibody were observed. Videofluoroscopy was useful in assessing the severity of the dysphagia and in making an accurate diagnosis; both laryngeal elevation and weakness of pharyngeal wall contraction were also observed. In two cases in which antiviral therapy was delayed, the outcome was poor, with increased levels of varicella-zoster virus immunoglobulin M found on enzyme immunoassay. The outcome of the condition may thus depend both on the speed of antiviral therapy commencement following onset of symptoms, and on the levels of varicella-zoster virus immunoglobulin M antibody (measured by enzyme immunoassay). Our study suggests that varicella-zoster virus should be considered in the differential diagnosis of patients with idiopathic associated laryngeal paralysis, and rapid antiviral therapy should be initiated when necessary.


1994 ◽  
Vol 1 (2) ◽  
pp. 186-188 ◽  
Author(s):  
T B Martins ◽  
T D Jaskowski ◽  
C Schroder ◽  
B Streeter ◽  
H R Hill

Vaccine ◽  
2013 ◽  
Vol 31 (19) ◽  
pp. 2343-2347 ◽  
Author(s):  
Masachi Hanaoka ◽  
Michi Hisano ◽  
Noriyoshi Watanabe ◽  
Kana Sugawara ◽  
Yukari Kambe ◽  
...  

1978 ◽  
Vol 8 (6) ◽  
pp. 733-735
Author(s):  
A A Gershon ◽  
S Piomelli ◽  
M Karpatkin ◽  
E Smithwick ◽  
S Steinberg

Antibody titers to varicella-zoster virus were measured in varicella-susceptible immunocompromised children 48 h after they received either one of two lots of zoster immune globulin (ZIG) or a selected lot of immune serum globulin (ISG). Globulin was given to modify varicella in these children after exposure to varicella or zoster. Indirect immunofluorescence antibody titers (FAMA) of children after receipt of globulin ranged from less than 1:2 to 1:32. Geometric mean FAMA titers were highest after 1.2 ml of ISG per kg (FAMA titer 1:128) and 0.16 ml of ZIG lot A per kg (FAMA titer 1:1,024). Selected batches of ISG titering 1:128 or greater by FAMA, at a dose of 1.2 ml/kg, may be used to attempt to modify varicella in susceptible high-risk individuals when ZIG is not available.


Sign in / Sign up

Export Citation Format

Share Document